PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 157 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,360 | -24.0% | 39,240 | -36.5% | 0.00% | -100.0% |
Q1 2024 | $1,789 | -47.6% | 61,819 | -58.5% | 0.00% | 0.0% |
Q4 2023 | $3,415 | +15.8% | 148,974 | -15.8% | 0.00% | -50.0% |
Q3 2023 | $2,950 | -44.8% | 176,837 | -8.6% | 0.00% | -33.3% |
Q2 2023 | $5,344 | -60.2% | 193,439 | -66.9% | 0.00% | -50.0% |
Q1 2023 | $13,427 | +382.8% | 583,737 | +129.0% | 0.01% | +500.0% |
Q4 2022 | $2,781 | -99.8% | 254,887 | +18.0% | 0.00% | -50.0% |
Q3 2022 | $1,820,000 | +878.5% | 215,994 | +817.9% | 0.00% | – |
Q2 2022 | $186,000 | -82.3% | 23,531 | -46.9% | 0.00% | -100.0% |
Q1 2022 | $1,050,000 | -87.3% | 44,302 | -81.6% | 0.00% | -50.0% |
Q4 2021 | $8,248,000 | +1157.3% | 241,194 | +551.9% | 0.00% | – |
Q3 2021 | $656,000 | +97.0% | 36,997 | +399.6% | 0.00% | – |
Q2 2021 | $333,000 | -66.1% | 7,405 | -80.4% | 0.00% | -100.0% |
Q1 2021 | $981,000 | +358.4% | 37,866 | +257.0% | 0.00% | – |
Q4 2020 | $214,000 | -24.6% | 10,608 | -27.0% | 0.00% | – |
Q3 2020 | $284,000 | +27.9% | 14,527 | +15.4% | 0.00% | – |
Q2 2020 | $222,000 | +428.6% | 12,591 | +113.7% | 0.00% | – |
Q1 2020 | $42,000 | -67.7% | 5,893 | -68.1% | 0.00% | – |
Q4 2019 | $130,000 | -25.3% | 18,454 | +27.3% | 0.00% | – |
Q3 2019 | $174,000 | -42.4% | 14,498 | -41.9% | 0.00% | – |
Q2 2019 | $302,000 | -62.8% | 24,975 | -61.3% | 0.00% | -100.0% |
Q1 2019 | $812,000 | +75.8% | 64,569 | -5.9% | 0.00% | – |
Q4 2018 | $462,000 | +181.7% | 68,602 | +179.7% | 0.00% | – |
Q2 2018 | $164,000 | +60.8% | 24,527 | +106.5% | 0.00% | – |
Q1 2018 | $102,000 | -40.4% | 11,877 | +44.6% | 0.00% | – |
Q4 2017 | $171,000 | +4175.0% | 8,216 | +3703.7% | 0.00% | – |
Q3 2017 | $4,000 | -20.0% | 216 | -53.4% | 0.00% | – |
Q2 2017 | $5,000 | -75.0% | 464 | -71.6% | 0.00% | – |
Q1 2017 | $20,000 | +300.0% | 1,635 | +650.0% | 0.00% | – |
Q4 2016 | $5,000 | – | 218 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $84,864,191 | 21.18% |
Cannon Global Investment Management, LLC | 69,900 | $2,422,035 | 11.28% |
ADAR1 Capital Management, LLC | 1,603,932 | $55,576,244 | 10.49% |
Checkpoint Capital L.P. | 355,000 | $12,300,750 | 7.42% |
Fairmount Funds Management LLC | 931,890 | $32,289,989 | 3.65% |
BVF INC/IL | 3,319,290 | $115,013,399 | 3.22% |
RTW INVESTMENTS, LP | 5,286,404 | $183,173,899 | 2.84% |
Kynam Capital Management, LP | 800,000 | $27,720,000 | 2.14% |
683 Capital Management, LLC | 604,449 | $20,944,158 | 1.58% |
Birchview Capital, LP | 48,000 | $1,663,200 | 1.54% |